Government reforms aimed at lowering drug prices are needed because market-based reforms haven’t been able to bring about enough change, according to a recent survey of the health insurance concerns of large US employers conducted by the Business Group on Health.
Sixty-two percent of respondents believe both market-based and government reforms are needed to make the drug market competitive enough to...







